Prevalence and risk factors of atrophic gastritis and intestinal metaplasia: a nationwide multicenter prospective study in Korea
- PMID: 23710311
- PMCID: PMC3661962
- DOI: 10.5009/gnl.2013.7.3.303
Prevalence and risk factors of atrophic gastritis and intestinal metaplasia: a nationwide multicenter prospective study in Korea
Abstract
Background/aims: Atrophic gastritis (AG) and intestinal metaplasia (IM) are premalignant gastric lesions. The aims of this study were to evaluate the prevalence of endoscopic AG and IM and to document the risk factors for these lesions.
Methods: In total, 4,023 subjects were enrolled at eight hospitals in Korea. AG and IM were diagnosed by endoscopy. Helicobacter pylori immunoglobulin G antibodies were measured.
Results: The prevalences of endoscopic AG and IM were 40.7% and 12.5%. In a multivariate analysis, the risk factors for AG were age groups of 40 to 59 years and >60 years, male sex, positive H. pylori serology, IM, and education below the college level (odds ratio [OR], 2.55, 5.00, 1.38, 1.41, 4.29, and 1.35, respectively). The risk factors for IM were age groups of 40 to 59 years and >60 years, male sex, positive H. pylori serology, AG, having relatives with gastric cancer, education below the college level and consumption of dairy products (OR, 3.16, 3.25, 1.88, 2.17, 3.68, 1.48, 1.47, and 1.40, respectively).
Conclusions: A nationwide survey regarding the prevalence of endoscopic AG and IM and their risk factors in Korea supports the hypothesis that endoscopic diagnosis of these premalignant lesions could be helpful to describe a group at high risk for gastric cancer.
Keywords: Atrophic gastritis; Endoscopy; Intestinal metaplasia; Prevalence; Risk factors.
Conflict of interest statement
No potential conflict of interest relevant to this article was reported.
Figures
Similar articles
-
Prevalence and factors associated with atrophic gastritis and intestinal metaplasia: A multivariate, hospital-based, statistical analysis.Cancer Epidemiol. 2023 Feb;82:102309. doi: 10.1016/j.canep.2022.102309. Epub 2022 Dec 5. Cancer Epidemiol. 2023. PMID: 36470067
-
Review of atrophic gastritis and intestinal metaplasia as a premalignant lesion of gastric cancer.J Cancer Prev. 2015 Mar;20(1):25-40. doi: 10.15430/JCP.2015.20.1.25. J Cancer Prev. 2015. PMID: 25853101 Free PMC article. Review.
-
Role of endoscopy in suspicion of atrophic gastritis with and without intestinal metaplasia in comparison to histopathology.Acta Gastroenterol Belg. 2021 Jan-Mar;84(1):9-17. doi: 10.51821/84.1.208. Acta Gastroenterol Belg. 2021. PMID: 33639688
-
Regulation of apoptosis is impaired in atrophic gastritis associated with gastric cancer.BMC Gastroenterol. 2017 Jun 29;17(1):84. doi: 10.1186/s12876-017-0640-7. BMC Gastroenterol. 2017. PMID: 28662697 Free PMC article.
-
[Reversibility of Atrophic Gastritis and Intestinal Metaplasia by Eradication of Helicobacter pylori].Korean J Gastroenterol. 2018 Sep 25;72(3):104-115. doi: 10.4166/kjg.2018.72.3.104. Korean J Gastroenterol. 2018. PMID: 30270592 Review. Korean.
Cited by
-
AGA Technical Review on Gastric Intestinal Metaplasia-Epidemiology and Risk Factors.Gastroenterology. 2020 Feb;158(3):732-744.e16. doi: 10.1053/j.gastro.2019.12.002. Epub 2019 Dec 6. Gastroenterology. 2020. PMID: 31816301 Free PMC article. No abstract available.
-
Effect of Citric Acid on Accuracy of 13C-Urea Breath Test after Helicobacter pylori Eradication Therapy in a Region with a High Prevalence of Atrophic Gastritis.Gut Liver. 2019 Sep 15;13(5):506-514. doi: 10.5009/gnl18398. Gut Liver. 2019. PMID: 30970440 Free PMC article.
-
Incidence and prevalence of gastric neuroendocrine tumors in patients with chronic atrophic autoimmune gastritis.World J Gastrointest Oncol. 2023 Aug 15;15(8):1451-1460. doi: 10.4251/wjgo.v15.i8.1451. World J Gastrointest Oncol. 2023. PMID: 37663936 Free PMC article.
-
Fermented Gold Kiwi for Improved Gastric Health: Evaluation of Efficacy and Safety in a Randomised, Double-Blind, Placebo-Controlled Trial.Nutrients. 2024 Aug 13;16(16):2670. doi: 10.3390/nu16162670. Nutrients. 2024. PMID: 39203808 Free PMC article. Clinical Trial.
-
Clinical Practice Guideline for Gastritis in Korea.J Korean Med Sci. 2023 Apr 3;38(13):e115. doi: 10.3346/jkms.2023.38.e115. J Korean Med Sci. 2023. PMID: 37012690 Free PMC article.
References
-
- Katanoda K, Yako-Suketomo H. Comparison of time trends in stomach cancer incidence (1973-2002) in Asia, from cancer incidence in five continents, vols IV-IX. Jpn J Clin Oncol. 2009;39:71–72. - PubMed
-
- Yuasa N, Nimura Y. Survival after surgical treatment of early gastric cancer, surgical techniques, and long-term survival. Langenbecks Arch Surg. 2005;390:286–293. - PubMed
-
- Hundahl SA, Phillips JL, Menck HR. The National Cancer Data Base Report on poor survival of U.S. gastric carcinoma patients treated with gastrectomy: fifth edition American Joint Committee on Cancer staging, proximal disease, and the "different disease" hypothesis. Cancer. 2000;88:921–932. - PubMed
-
- de Vries AC, Haringsma J, Kuipers EJ. The detection, surveillance and treatment of premalignant gastric lesions related to Helicobacter pylori infection. Helicobacter. 2007;12:1–15. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical